INFANDX HYPOXE-TEST
LIVE

Serial Number

79234733

Owner

InfanDx AG

Attorney

George A. Metzenthin

Filing Date

Mar 16, 2018

Add to watchlist:

No watchlists yet
View on USPTO

INFANDX HYPOXE-TEST Trademark

Serial Number: 79234733 • Registration: 5736328

INFANDX HYPOXE-TEST is a trademark filed by InfanDx AG on March 16, 2018. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 16 (Paper Goods). The application is currently registered and active.

Owner Contact Info

InfanDx AG (3 trademarks)

Balthasarstr. 18

Entity Type: 25

Trademark Details

Filing Date

March 16, 2018

Registration Date

April 30, 2019

Published for Opposition

February 12, 2019

Cancellation Date

November 14, 2025

Goods & Services

Medical and veterinary equipment, apparatus and instruments for treating asphyxia, hypoxic-ischemic encephalopathy, or brain injury; analytical equipment for the analysis of body fluids; diagnostic equipment for medical purposes in diagnosing asphyxia, hypoxic-ischemic encephalopathy, or brain injury; all of the aforementioned goods in this class only

Scientific apparatus, instruments and devices, namely, photometers, fluorometers, flow meters, apparatus and instruments for electrophoresis and mass spectrometry, liquid chromatography instruments, gas chromatography instruments, plasmone resonance spectrometers, and electrodes for research and examination purposes, and laboratory consumables for the above mentioned apparatus, instruments and devices, namely, laboratory filters, pipetting tips, and optical filters; all of the aforementioned goods in this class only

Printed matter, namely, books, brochures and texts, all in the field of neonatal care, asphyxia, and multilevel multivariate biomarkers; printed educational materials in the field of neonatal care, asphyxia, and multilevel multivariate biomarkers; teaching materials in the field of neonatal care, asphyxia, and multilevel multivariate biomarkers; all of the aforementioned goods in this class only

Diagnostic reagents; diagnostic kits consisting of medical diagnostic reagents for detecting metabolites for use in diagnosis of asphyxia, hypoxic-ischemic encephalopathy, or brain injury; all of the aforementioned goods in this class only

Filing History

CANCELLED SECTION 71
Nov 14, 2025 C71T
NEW REPRESENTATIVE AT IB RECEIVED
May 19, 2024 NREP
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Apr 30, 2024 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Sep 13, 2019 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Aug 22, 2019 FICS
FINAL DISPOSITION PROCESSED
Aug 22, 2019 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jul 30, 2019 FICR
REGISTERED-PRINCIPAL REGISTER
Apr 30, 2019 R.PR
PUBLISHED FOR OPPOSITION
Feb 12, 2019 PUBO
NOTIFICATION PROCESSED BY IB
Feb 8, 2019 GPNX
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 23, 2019 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 23, 2019 REAP
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jan 23, 2019 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jan 23, 2019 OP2R
NOTICE OF PUBLICATION
Jan 23, 2019 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 4, 2019 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 3, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 2, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 2, 2019 TROA
REFUSAL PROCESSED BY IB
Aug 7, 2018 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jul 17, 2018 RFCS
REFUSAL PROCESSED BY MPU
Jul 17, 2018 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jul 6, 2018 RFCR
NON-FINAL ACTION WRITTEN
Jul 5, 2018 CNRT
ASSIGNED TO EXAMINER
Jun 26, 2018 DOCK
APPLICATION FILING RECEIPT MAILED
Jun 26, 2018 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 22, 2018 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jun 21, 2018 REPR